You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 7, February 16, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  This Week in JAMA
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

This Week in JAMA

JAMA. 2000;283:841.

UNIVERSITY OF MICHIGAN MEDICAL SCHOOL SESQUICENTENNIAL ISSUE

Edited by Helene M. Cole, MD, and Howard Markel, MD, PhD


The original 1850 building of the University of Michigan Medical School on the university campus in Ann Arbor, which housed several lecture rooms, faculty offices, a chemistry laboratory, and a room for human anatomical dissections.



Screening Frequency for Diabetic Retinopathy

Retinal screening for diabetic eye disease every second or third year may achieve a similar benefit as annual screening in most patients with type 2 diabetes mellitus. Using characteristics of individuals older than 40 years with type 2 diabetes in the Third National Health and Nutrition Examination Survey, Vijan and colleagues created a Markov model to estimate the cost-effectiveness of various screening intervals for detection of diabetic retinopathy. Predicted time spent blind according to different screening intervals (every year, every third year, every fifth year) varied with age and level of glycemic control, with high-risk patients gaining an average of 21 days of sight with annual screening compared with every third year and low-risk patients gaining 3 days of sight. Estimated cost per quality-adjusted life-year gained was $107,510 for annual screening compared with every other year and $49,760 for screening every other year compared with every third year.

(SEE ARTICLE)


Presentation and Outcomes of Acute Aortic Dissection

In this descriptive analysis of the presentation, management, and outcomes of 464 patients with acute aortic dissection enrolled in the International Registry of Acute Aortic Dissection beginning January 1, 1996, Hagan and colleagues conclude that despite recent diagnostic and therapeutic advances, in-hospital mortality remains high and continued improvement in diagnosis and management is needed. The most common presenting symptom of acute aortic dissection was sudden onset of severe sharp pain and classic physical findings of aortic regurgitation and pulse deficit were often absent. Initial chest film was normal in 12.4% of patients and 31.3% had a normal electrocardiogram. Overall in-hospital mortality was 27.4%. Among patients with type A dissection, mortality was 26% in those managed surgically and 58% in those who did not receive surgery. Mortality among patients with type B dissection treated with surgery was 31.4% and 10.7% among those treated medically.

(SEE ARTICLE)


Extracorporeal Life Support Program at U of M

The extracorporeal life support (ECLS) program at the University of Michigan (U of M) was established in 1980. Reporting on a series of 1000 consecutive patients between 1980 and 1998, Bartlett and coauthors describe changes in the type of cases managed with ECLS over time and patient characteristics and outcomes, and discuss the development and application of ECLS technology.

(SEE ARTICLE)


Family-Physician Conflicts About End-of-Life Care

Conflicts between families and physicians often beset decisions to limit treatment at the end of life. Goold and coauthors describe 3 categories of factors that contribute to family-physician conflicts regarding life-sustaining treatment—family features, physician features, and organizational and social features—and present a model based on differential diagnosis to identify underlying causes of disagreement.

(SEE ARTICLE)


University of Michigan Medical School, 1850-2000

Markel traces the history of the University of Michigan Medical School from the time of its proposal to the board of regents of the university in 1847 to the present.

(SEE ARTICLE)


ERISA and Physician Autonomy

Jacobson and Pomfret discuss how the federal Employee Retirement Income Security Act (ERISA), by preempting state regulation of managed care organizations (MCOs), protects MCOs from medical liability lawsuits, influences clinical decision making, and erodes physician autonomy.

(SEE ARTICLE)


Contempo Updates

Emergency use of magnetic resonance imaging for evaluation of acute central nervous system conditions.

(SEE ARTICLE)


Medical News & Perspectives

Fine-tuning a programmable patient simulator, innovations in pediatric cardiac surgery, and a possible first treatment for Duchenne muscular dystrophy are part of the research agenda at the University of Michigan Medical School.

(SEE ARTICLE)


U of M Medical School Shapes Its Future

The University of Michigan (U of M) Medical School responds to the financial stress facing academic medical centers with creative organizational changes, cost control measures, and renewed commitment to education, research, and patient-centered health care.

(SEE ARTICLE)


JAMA Patient Page

For your patients: Preventive eye care.

(link unavailable)







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.